COM:PLIANTRX
Pliant Therapeutics
- Stock
Last Close
12.73
21/11 21:00
Market Cap
669.01M
Beta: -
Volume Today
687.71K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
net income | -30.28M - | -631K 97.92% | -41.53M 6,482.09% | -97.26M 134.18% | -123.32M 26.79% | -161.34M 30.83% | |
depreciation and amortization | 666K - | 1.11M 67.12% | 1.31M 17.70% | 1.53M 17.18% | 1.82M 18.76% | 1.84M 0.99% | |
deferred income tax | -12.20M - | -4.95M - | |||||
stock based compensation | 228K - | 1.83M 702.19% | 3.90M 112.96% | 10.44M 167.96% | 22.60M 116.52% | 44.48M 96.84% | |
change in working capital | 1.05M - | -5.06M 580.17% | -1.21M 76.11% | 6.92M 672.13% | 4.22M 39.03% | 1.25M 70.33% | |
accounts receivables | -7.05M - | -2.23M 68.42% | 7.28M 426.94% | 15K 99.79% | 1.98M 13,120.00% | ||
inventory | 3.20M - | 113K 96.46% | |||||
accounts payables | 760K - | -1.25M 265.13% | 922K 173.47% | 891K 3.36% | -1.35M 251.63% | 2.97M 319.76% | |
other working capital | 294K - | 50K 82.99% | -17K 134% | -1.25M 7,282.35% | 5.55M 542.47% | -3.70M 166.65% | |
other non cash items | 12.20M - | 266K 97.82% | 2.93M 1,001.88% | 52K 98.23% | 2.35M 4,423.08% | ||
net cash provided by operating activities | -28.33M - | -2.75M 90.29% | -37.27M 1,255.31% | -75.44M 102.42% | -94.63M 25.43% | -116.36M 22.96% | |
investments in property plant and equipment | -2.32M - | -964K 58.50% | -1.53M 58.92% | -1.95M 27.48% | -1.76M 9.88% | -921K 47.67% | |
acquisitions net | 254K - | 209.33M 82,314.96% | -75.65M 136.14% | 148.44M 296.22% | |||
purchases of investments | -51.97M - | -322.61M 520.79% | -219.89M 31.84% | -325.72M 48.13% | -583.07M 79.01% | ||
sales maturities of investments | 35M - | 113.27M 223.63% | 295.54M 160.91% | 177.27M 40.02% | 456.98M 157.78% | ||
other investing activites | -254K - | -209.33M 82,314.96% | 75.65M 136.14% | -148.44M 296.22% | |||
net cash used for investing activites | -2.32M - | -17.93M 671.89% | -210.87M 1,075.99% | 73.70M 134.95% | -150.20M 303.81% | -127.01M 15.44% | |
debt repayment | |||||||
common stock issued | 32K - | 48.12M 150,278.13% | 160.75M 234.06% | 2.98M 98.14% | 217.56M 7,190.92% | 269.40M 23.83% | |
common stock repurchased | |||||||
dividends paid | |||||||
other financing activites | 87.32M - | -2.58M 102.96% | 52.46M 2,131.80% | -457K 100.87% | 9.29M 2,133.48% | 5.00M 46.19% | |
net cash used provided by financing activities | 87.35M - | 45.54M 47.87% | 213.21M 368.20% | 2.53M 98.81% | 226.85M 8,877.21% | 274.40M 20.96% | |
effect of forex changes on cash | -1.48M - | ||||||
net change in cash | 56.70M - | 24.86M 56.16% | -34.92M 240.50% | 783K 102.24% | -17.98M 2,396.42% | 29.55M 264.33% | |
cash at beginning of period | 4.25M - | 60.95M 1,333.76% | 85.81M 40.78% | 50.88M 40.70% | 51.66M 1.54% | 33.69M 34.80% | |
cash at end of period | 60.95M - | 85.81M 40.78% | 50.88M 40.70% | 51.66M 1.54% | 33.68M 34.80% | 63.23M 87.73% | |
operating cash flow | -28.33M - | -2.75M 90.29% | -37.27M 1,255.31% | -75.44M 102.42% | -94.63M 25.43% | -116.36M 22.96% | |
capital expenditure | -2.32M - | -964K 58.50% | -1.53M 58.92% | -1.95M 27.48% | -1.76M 9.88% | -921K 47.67% | |
free cash flow | -30.65M - | -3.71M 87.88% | -38.80M 944.78% | -77.40M 99.46% | -96.39M 24.54% | -117.28M 21.67% |
All numbers in (except ratios and percentages)